Yervoy Bristol-Myers Squibb Australia Pty Ltd
Product name
Yervoy
Accepted date
Sep-2024
Active ingredients
Ipilimumab
Proposed indication
For the treatment of advanced hepatocellular carcinoma or hepatocellular carcinoma that cannot be removed surgically.
Application type
C (new indication)
Publication date
Sep-2024